Fig. 1

Survey disposition. LA SSA = long-acting somatostatin analog. ^aReported receipt of another LA SSA since baseline. ^bFour completed but not submitted baseline surveys were moved to completed status at the end of data collection. ^cThere were 2 patients who screened into the baseline survey, which indicated that it had been less than 5 days since their most recent LA SSA injection. These patients later provided the date of their last injection as occurring 15 and 25 days before taking the survey. The completed surveys for these 2 patients were not included in the analysis data set